WOODROW A JR MYERS
CIK 1243399 · last filed 2026-05-14
WOODROW A JR MYERS is a corporate insider who has filed 68 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for PSNL, was dated May 14, 2026. Across all open-market trades the lifetime net is −$6.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $317.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$317.7K
7
68
-$6.87M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PSNL | Director | 32,366 | $9.59 | $310.4K | $16.7K | 8 | 2026-05-14 |
| Keenova Therapeutics plc (MNK) Delisted | Director | 49,399 | $0.34 | $16.8K | $0 | 4 | 2023-06-29 |
| Express Scripts Holding Co. (ESRX) Delisted | Director | 0 | — | — | -$5.17M | 25 | 2018-12-21 |
| GENOMIC HEALTH INC (GHDX) Delisted | Director | 3,880 | — | — | -$1.71M | 23 | 2013-10-03 |
| LIPOSCIENCE INC (LPDX) Delisted | Director | 1,122 | — | — | $0 | 1 | 2013-06-14 |
| KOOL | Director | — | $14.29 | — | $0 | 3 | 2009-07-06 |
| BEAT | Director | 9,614 | $0.76 | $7.3K | $0 | 3 | 2009-01-26 |
Recent Filings
68 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-14 | PSNL | Grant (A) | +6,250 | $0 | EDGAR |
| 2025-05-20 | PSNL | Grant (A) | — | $0 | EDGAR |
| 2024-05-21 | PSNL | Grant (A) | — | $0 | EDGAR |
| 2024-03-05 | PSNL | Buy (P) | +10,000 | $16.7K | EDGAR |
| 2023-11-16 | — | Disp (D) | −23,122 | $0 | |
| 2023-06-29 | Keenova Therapeutics plc (MNK) Delisted | Mixed | −29,431 | -$4.0K | EDGAR |
| 2023-05-19 | PSNL | Grant (A) | — | $0 | EDGAR |
| 2023-01-05 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | +26,277 | $0 | EDGAR |
| 2022-09-14 | Keenova Therapeutics plc (MNK) Delisted | Disp (D) | — | $0 | EDGAR |
| 2022-07-06 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | — | $0 | EDGAR |